The impact of artificial sweeteners on the metabolic syndrome
DOI:
https://doi.org/10.12775/JEHS.2024.66.013Keywords
Metabolic syndrome, artificial sweeteners, obesity, diabetesAbstract
Introduction: Metabolic syndrome is a wide-spread disease that affects even 30% of Polish population. The mentioned syndrome consists of: glucose intolerance, obesity, dyslipidaemia and high blood pressure. Change of lifestyle, particularly diet, is a crucial part of treatment of those issues. Artificial sweeteners are low-calorie or non-nutritive substances that are made for lowering sugar amounts in sweetened beverages. The use of artificial sweeteners rises among those, who want to lower their weight. Artificial sweeteners are well known substances, but their impact on health is still a matter of studies. We want to summarize the current knowledge about their impact on metabolic syndrome and its elements.
Objectives: The review and presentation of the current state of knowledge on impact of artificial sweeteners on metabolic syndrome and its components.
Material and methods: Review of the studies available on open access sources at PubMed, Google Scholar, National Library of Medicine and Coachrane.
Conclusions: Currently there is no evidence of positive impact of artificial sweeteners on the metabolic syndrome. Moreover, new studies prove a negative impact of those substances at obesity, glucose intolerance, dyslipidaemia and blood pressure. However there is a need of further studies about physiology of gut microbiota and current subject to strengthen current depth of evidence.
References
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2):12.
Tinajero MG, Malik VS. An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. Endocrinol Metab Clin North Am. 2021;50(3):337-55.
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020;21(17).
Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2019;127(S 01):S1-s7.
Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract. 2005;67(2):152-62.
Sattar N, Welsh P, Leslie WS, Thom G, McCombie L, Brosnahan N, et al. Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby). Lancet Reg Health Southeast Asia. 2023;9:100111.
Barnes AS. The epidemic of obesity and diabetes: trends and treatments. Tex Heart Inst J. 2011;38(2):142-4.
Iizuka K. Is the Use of Artificial Sweeteners Beneficial for Patients with Diabetes Mellitus? The Advantages and Disadvantages of Artificial Sweeteners. Nutrients. 2022;14(21).
Gardner C, Wylie-Rosett J, Gidding SS, Steffen LM, Johnson RK, Reader D, Lichtenstein AH. Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2012;126(4):509-19.
Fernstrom JD. Non-nutritive sweeteners and obesity. Annu Rev Food Sci Technol. 2015;6:119-36.
Tey SL, Salleh NB, Henry CJ, Forde CG. Effects of non-nutritive (artificial vs natural) sweeteners on 24-h glucose profiles. Eur J Clin Nutr. 2017;71(9):1129-32.
Henry CJ, Newens KJ, Lightowler HJ. Low-glycaemic index sweetener-based beverages reduce 24-h glucose profiles in healthy adults. J Hum Nutr Diet. 2009;22(1):77-80.
Brynes AE, Lee JL, Brighton RE, Leeds AR, Dornhorst A, Frost GS. A low glycemic diet significantly improves the 24-h blood glucose profile in people with type 2 diabetes, as assessed using the continuous glucose MiniMed monitor. Diabetes Care. 2003;26(2):548-9.
Santos NC, de Araujo LM, De Luca Canto G, Guerra ENS, Coelho MS, Borin MF. Metabolic effects of aspartame in adulthood: A systematic review and meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr. 2018;58(12):2068-81.
Solomi L, Rees GA, Redfern KM. The acute effects of the non-nutritive sweeteners aspartame and acesulfame-K in UK diet cola on glycaemic response. Int J Food Sci Nutr. 2019;70(7):894-900.
Walbolt J, Koh Y. Non-nutritive Sweeteners and Their Associations with Obesity and Type 2 Diabetes. J Obes Metab Syndr. 2020;29(2):114-23.
Lohner S, de Gaudry DK, Toews I, Ferenci T, Meerpohl JJ. Non‐nutritive sweeteners for diabetes mellitus. Cochrane database of systematic reviews. 2020(5).
Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514(7521):181-6.
Nakagawa Y, Nagasawa M, Mogami H, Lohse M, Ninomiya Y, Kojima I. Multimodal function of the sweet taste receptor expressed in pancreatic β-cells: generation of diverse patterns of intracellular signals by sweet agonists. Endocr J. 2013;60(10):1191-206.
De la Hunty A, Gibson S, Ashwell M. A review of the effectiveness of aspartame in helping with weight control. Nutrition Bulletin. 2006;31(2):115-28.
Rogers PJ, Hogenkamp PS, de Graaf C, Higgs S, Lluch A, Ness A, et al. Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. International Journal of Obesity. 2016;40(3):381-94.
Tey S, Salleh N, Henry J, Forde C. Effects of aspartame-, monk fruit-, stevia-and sucrose-sweetened beverages on postprandial glucose, insulin and energy intake. International journal of obesity. 2017;41(3):450-7.
Rogers PJ, Appleton KM. The effects of low-calorie sweeteners on energy intake and body weight: a systematic review and meta-analyses of sustained intervention studies. International journal of obesity. 2021;45(3):464-78.
Pan A, Malik VS, Hao T, Willett WC, Mozaffarian D, Hu FB. Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies. International journal of obesity. 2013;37(10):1378-85.
Azad MB, Abou-Setta AM, Chauhan BF, Rabbani R, Lys J, Copstein L, et al. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. Cmaj. 2017;189(28):E929-E39.
Debras C, Chazelas E, Sellem L, Porcher R, Druesne-Pecollo N, Esseddik Y, et al. Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort. Bmj. 2022;378.
Laffitte A, Neiers F, Briand L. Functional roles of the sweet taste receptor in oral and extraoral tissues. Current Opinion in Clinical Nutrition & Metabolic Care. 2014;17(4):379-85.
Higgins KA, Rawal R, Baer DJ, O'Connor LE, Appleton KM. Scoping review and evidence map of the relation between exposure to dietary sweetness and body weight-related outcomes in adults. Advances in Nutrition. 2022;13(6):2341-56.
Swithers SE. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends in Endocrinology & Metabolism. 2013;24(9):431-41.
Kim J-Y, Park K-H, Kim J, Choi I, Cho K-H. Modified high-density lipoproteins by artificial sweetener, aspartame, and saccharin, showed loss of anti-atherosclerotic activity and toxicity in zebrafish. Cardiovascular toxicology. 2015;15:79-89.
Movahedian M, Golzan SA, Ashtary-Larky D, Clark CC, Asbaghi O, Hekmatdoost A. The effects of artificial-and stevia-based sweeteners on lipid profile in adults: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Critical reviews in food science and nutrition. 2023;63(21):5063-79.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The lancet. 2005;365(9468):1415-28.
Rios-Leyvraz M, Montez J, Organization WH. Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. 2022.
Pase MP, Himali JJ, Beiser AS, Aparicio HJ, Satizabal CL, Vasan RS, et al. Sugar-and artificially sweetened beverages and the risks of incident stroke and dementia: a prospective cohort study. Stroke. 2017;48(5):1139-46.
Tayel DI, El-Sayed NA, El-Sayed NA. Dietary pattern and blood pressure levels of adolescents in Sohag, Egypt. The Journal Of The Egyptian Public Health Association. 2013;88(2):97-103.
Toews I, Lohner S, de Gaudry DK, Sommer H, Meerpohl JJ. Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies. bmj. 2019;364.
Cheungpasitporn W, Thongprayoon C, Edmonds PJ, Srivali N, Ungprasert P, Kittanamongkolchai W, Erickson SB. Sugar and artificially sweetened soda consumption linked to hypertension: a systematic review and meta-analysis. Clinical and Experimental Hypertension. 2015;37(7):587-93.
Spencer M, Gupta A, Van Dam L, Shannon C, Menees S, Chey WD. Artificial sweeteners: a systematic review and primer for gastroenterologists. Journal of neurogastroenterology and motility. 2016;22(2):168.
Cohen L, Curhan G, Forman J. Association of sweetened beverage intake with incident hypertension. J Gen Intern Med. 2012;27(9):1127-34.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Filip Czyżewski, Alicja Baranowska, Katarzyna Baranowska, Kinga Filipek, Jakub Kawka, Michał Muciek, Sebastian Mrugała, Waldemar Mrugała, Bartosz Skierkowski, Natalia Zalewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 509
Number of citations: 0
